Tissue-level modeling of xenobiotic metabolism in liver: An emerging tool for enabling clinical translational research
- PMID: 20443896
- PMCID: PMC3068531
- DOI: 10.1111/j.1752-8062.2009.00092.x
Tissue-level modeling of xenobiotic metabolism in liver: An emerging tool for enabling clinical translational research
Abstract
This review summarizes some of the recent developments and identifies critical challenges associated with in vitro and in silico representations of the liver and assesses the translational potential of these models in the quest of rationalizing the process of evaluating drug efficacy and toxicity. It discusses a wide range of research efforts that have produced, during recent years, quantitative descriptions and conceptual as well as computational models of hepatic processes such as biotransport and biotransformation, intra- and intercellular signal transduction, detoxification, etc. The above mentioned research efforts cover multiple scales of biological organization, from molecule-molecule interactions to reaction network and cellular and histological dynamics, and have resulted in a rapidly evolving knowledge base for a "systems biology of the liver." Virtual organ/organism formulations represent integrative implementations of particular elements of this knowledge base, usually oriented toward the study of specific biological endpoints, and provide frameworks for translating the systems biology concepts into computational tools for quantitative prediction of responses to stressors and hypothesis generation for experimental design.
Figures







References
-
- Merrick BA. Toxicoproteomics in liver injury and inflammation. Ann N YAcod Sci. 2006; 1076 707–717. - PubMed
-
- Dome JL, Skinner L, Frampton GK, Spurgeon DJ, Ragas AM. Human and environmental risk assessment of pharmaceuticals: differences, similarities, lessons from toxicology. Anal Bioonol Chem. 2007; 387(4): 1259–1268. - PubMed
-
- Burke W, Psaty BM. Personalized medicine in the era of genomics. JAMA. 2007; 298(14) 1682–1684. - PubMed
-
- Liu ET. Expression genomics and drug development: towards predictive pharmacology. Brief Fund Cenomic Proteomic. 2005; 3(4): 303–321. - PubMed
-
- Hunt CA, Ropella GE, Yan L, Hung DY, Roberts MS. Physiologically based synthetic models of hepatic disposition. J Pharmacokinet Pharmacodyn. 2006; 33(6): 737–772 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources